23 In December 1987, Stephen Blooms team confirmed in a Lancet paper that GLP-1(7-36) is a human intestinal hormone that stimulates insulin production in the pancreas and lowers blood sugar
The Current State of GLP-1 Drugs 2023 research from IQVIA has shown that demand for GLP-1 drugs has accelerated since early 2020, corresponding to the launches of Ozempic, Wegovy and Mounjaro variations
But I hope for Hims & Hers sake it was able to look past the short term cash cow (and its very clear theyve seen tons of growth from the weight loss segment as well as the cross sell potential there into other verticals), as the other segments of the business are doing great, and its a solid, growing business
Pocai A, Carrington PE, Adams JR, Wright M, Eiermann G, Zhu L, Du X, Petrov A, Lassman ME, Jiang G, Liu F, Miller C, Tota LM, Zhou G, Zhang X, Sountis MM, Santoprete A, Capito E, Chicchi GG, Thornberry N, Bianchi E, Pessi A, Marsh DJ, Sinha RR
Its easy to administer, but can be moderately uncomfortable, and requires you to be mindful of skin texture like scars, moles, or stretch marks
While this is the case for most new medicines, its particularly important for those that work on several hormone pathways simultaneously